Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Int J Drug Policy. 2018 Feb;52:97-101. doi: 10.1016/j.drugpo.2017.12.003. Epub 2017 Dec 24.
Misuse of prescription opioid analgesics (POA) has increased dramatically in the US, particularly in non-urban areas. We examined injection practices among persons who inject POA in a rural area that experienced a large HIV outbreak in 2015.
Between August-September 2015, 25 persons who injected drugs within the past 12 months were recruited in Scott County, Indiana for a qualitative study. Data from in-depth, semi-structured interviews were analyzed.
All 25 participants were non-Hispanic white and the median age was 33 years (range: 19-57). All had ever injected extended-release oxymorphone (Opana ER) and most (n=20) described preparing Opana ER for multiple injections per injection episode (MIPIE). MIPIE comprised 2-4 injections during an injection episode resulting from needing >1mL water to prepare Opana ER solution using 1mL syringes and the frequent use of "rinse shots." MIPIE occurred up to 10 times/day (totaling 35 injections/day), often in the context of sharing drug and injection equipment.
We describe a high-risk injection practice that may have contributed to the rapid spread of HIV in this community. Efforts to prevent bloodborne infections among people who inject POA need to assess for MIPIE so that provision of sterile injection equipment and safer injection education addresses the MIPIE risk environment.
在美国,处方类阿片类镇痛药(POA)的滥用现象急剧增加,尤其是在非城市地区。我们研究了在印第安纳州斯科特县经历了 2015 年大规模 HIV 疫情的农村地区,注射 POA 的人群的注射习惯。
2015 年 8 月至 9 月期间,在印第安纳州斯科特县招募了 25 名在过去 12 个月内注射过毒品的人,进行了一项定性研究。对深入的半结构式访谈数据进行了分析。
所有 25 名参与者均为非西班牙裔白人,中位年龄为 33 岁(范围:19-57 岁)。所有人都曾注射过缓释羟吗啡酮(Opana ER),大多数(n=20)人描述了为每次注射事件(MIPIE)准备 Opana ER 进行多次注射的情况。MIPIE 包括在一个注射事件中进行 2-4 次注射,这是由于使用 1 毫升注射器准备 Opana ER 溶液需要超过 1 毫升水,以及频繁使用“冲洗注射”造成的。MIPIE 每天最多发生 10 次(每天总共注射 35 次),通常在共享药物和注射设备的情况下发生。
我们描述了一种高风险的注射行为,这可能导致了该社区中 HIV 的迅速传播。预防注射 POA 的人群中血源性感染的努力需要评估 MIPIE,以便提供无菌注射设备和更安全的注射教育,以解决 MIPIE 风险环境。